Perma-Fix Doubles Mo-99 Production Design Scale-Up

Perma-Fix Medical doubled the scale-up of its process to produce Technetium-99m only a week after announcing an initial milestone to its design, the company announced yesterday. Earlier this year, Perma-Fix said that it needed to reconfigure its production process after realizing the market demand for the medical isotope used in millions of procedures annually called for a larger design. According to the company, the new scaled-up version withstood high levels of radiation, up to four curies, while still producing usable doses of Tc-99m. This milestone comes only a week after achieving a radiation limit of two curies. “Following our recent success at the 2 curie level, we have already attracted significant interest from within the industry—further validating the significance of our process,” Perma-Fix Environmental CEO Lou Centofanti said in a statement. “Given our latest success at the 4 curie level, and near term plans to scale up even further, we are moving forward aggressively with our plans to formalize additional partnerships, prepare for regulatory submission, and, ultimately, commence commercialization of the process.”